Back to search
FDAFDA · Food and drugs·Recall number Z-0357-2025

URINALYSIS KIT 4, SKU DYLAB1021; Component No. 503581

Published November 20, 2024 · Recall initiated: October 23, 2024

Summary

FDA records medical device Class II recall Z-0357-2025, published November 20, 2024 and initiated October 23, 2024. Recalling firm: MEDLINE INDUSTRIES, LP - Northfield; Status: Ongoing; Reported quantity: 626,305 Total Kits (US only); Lot: UDI-DI: 40195327109784 (Case); 10195327109783 (Ea) Lots: 22FBK384 22GBO520. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Specimen container included in kits is labeled as sterile, but has been identified to be non-sterile. Long-term consequences may include unnecessary treatment and/or prolonged hospitalization.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
MEDLINE INDUSTRIES, LP - Northfield
Distributor
US Nationwide distribution in the states of AL, CA, FL, GA, IL, KY, MO, MS, MT, TN, TX, VA and WA.
Lot
UDI-DI: 40195327109784 (Case); 10195327109783 (Ea) Lots: 22FBK384 22GBO520
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was URINALYSIS KIT 4, SKU DYLAB1021; Component No. 503581 recalled?

Yes. FDA published recall Z-0357-2025 on November 20, 2024. Reported hazard: Specimen container included in kits is labeled as sterile, but has been identified to be non-sterile. Long-term consequences may include unnecessary treatment and/or prolonged hospitalization.

What should I do if I have this product?

Voluntary: Firm initiated · Letter